Lack of association between toll-like receptor 4 gene polymorphisms and giant cell arteritis

Rheumatology

Volumn 50, Issue 9, 2011, Pages 1562-1568

  Alvarez Rodriguez, Lorena ^a   Lopez Hoyos, Marcos ^a   Beares, Ignacio ^a   Cacho, Pedro Muñoz ^b   Mata, Cristina ^c   Calvo Alen, Jaime ^c   Corrales, Alfonso ^a   Tripathi, Gaurav ^a   Blanco, Ricardo ^a   Garcia Unzueta, Maite ^a   Villa, Ignacio ^c   Martinez Taboada, Victor M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Servicio Cantabro de Salud   (Spain)

^c HOSPITAL SIERRALLANA   (Spain)

Author keywords

Gene polymorphism; Giant cell arteritis; Toll like receptor 4

Indexed keywords

CORTICOSTEROID; TOLL LIKE RECEPTOR 4;

AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GIANT CELL ARTERITIS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPAIN; TOLL-LIKE RECEPTOR 4;

EID: 80051471336     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker168     Document Type: Article

References (48)

1. Huston KA, Hunder GG, Lie JT, Kennedy KH, Elveback LR. Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
2. Lawrence RC, Helmick CG, Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41: 778-99.
3. Salvarani C, Cantini F, Boiardi L et al. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2002;347: 261-71.
4. Rodríguez-Valverde V, Sarabia JM, González-Gay MA et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 1997;102: 331-6.
5. Martinez-Taboada VM, Goronzy JJ, Weyand CM. Conceptos actuales sobre la patogenia de la arteritis de cé lulas gigantes. Rev Esp Reumatol 1994;21:293-9.
6. Martínez-Taboada VM, Bartolome MJ, Lopez-Hoyos M et al. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis. Semin Arthritis Rheum 2004;34: 454-64.
7. Pacheco MJ, Amado JA, Lopez-Hoyos M et al. Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003;32:266-72.
8. Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology 2003;42: 1055-61.
9. Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 2004;63:54-60.
10. Martinez-Taboada V, Hunder NNH, Hunder GG, Weyand CM, Goronzy JJ. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med 1996;74:695-703.
11. Brack A, Geisler A, Martínez-Taboada V, Younge BR, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;8:530-43.
12. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84.
13. Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, Weyand CM. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 2009;104: 488-95.
14. Wagner AD, Wittkop U, Prahst A et al. Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis. Clin Exp Rheumatol 2003;21:185-92.
15. Palomino-Morales R, Torres O, Vazquez-Rodriguez TR et al. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 2009;36:1501-6.
16. Boiardi L, Casali B, Farnetti E et al. Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol 2009;27(Suppl. 52):S40-4.
17. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6:823-35.
18. Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CE. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004;199:173-83.
19. Browning BL, Huebner C, Petermann I et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007;102: 2504-12.
20. Pabst S, Baumgarten G, Stremmel A et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143:420-6.
21. Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005;5:156-64.
22. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007;4:444-54.
23. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-92.
24. Arbour NC, Lorenz E, Schutte BC et al. Toll-like receptor 4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25: 187-91.
25. Ferwerda B, McCall MBB, Verheijen K et al. Functional consequences of Toll-like receptor 4 polymorphisms. Mol Med 2008;14:346-52.
26. Sanchez E, Orozco G, Lopez-Nevot MA et al. Polymorphism of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004;63:54-7.
27. Kilding R, Akil M, Till S et al. A biologically important single nucleotide polymorphism within the Toll-like receptor gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 2003;21:340-2.
28. Radstake TR, Franke B, Hanssen S et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004;50:999-1001.
29. Torok HP, Glas J, Tonenchi L et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004; 112:85-91.
30. Meguro A, Ota M, Katsuyama Y et al. Association of TLR4 polymorphisms with Behcet's disease. Ann Rheum Dis 2008;67:725-7.
31. Horie Y, Meguro A, Ota M et al. Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology 2009;48:638-42.
32. Snelgrove T, Lim S, Greenwood C et al. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 2007;34:368-70.
33. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
34. Martínez-Taboada V, Brack A, Hunder GG, Goronzy JJ, Weyand CM. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996; 23:1011-4.
35. Chuang T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
36. Armona J, Rodriguez Valverde V, Gonzalez-Gay MA et al. Arteritis de cé lulas gigantes. Estudio de 191 pacientes. Med Clin 1995;105:734-7.
37. Brack A, Martínez-Taboada VM, Stanson R, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
38. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 2001;31:22-4.
39. Jun J, Abraham E, Azam T et al. Individual LPS responsiveness depends on the variation of toll-like receptor (TLR) expression level. J Microbiol Biotechnol 2007;17: 1862-67.
40. Ju X, Clark G, Hart DN. Review of human DC subtypes. Methods Mol Biol 2010;595:3-20.
41. Weyand CM, Ma-Krupa W, Pryshchep O, Gröschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 2005;1062:195-208.
42. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-51.
43. González-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003;33:38-48.
44. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor 4 complex. J Immunol 2000;164:558-61.
45. Termeer C, Benedix F, Sleeman J et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
46. Okamura Y, Watari M, Jerud ES et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-33.
47. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003;130:180-92.
48. Ló pez-Hoyos M, Alvarez L, Ruiz Soto M et al. Serum levels of antibodies to Chlamydia pneumoniae and human HSP60 in giant cell arteritis patients. Clin Exp Rheumatol 2008;26:1107-10.